Skip to content

PACHECO: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PACHECO

BE 0406.926.084
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€17,991
2024 · €60,443-€42,452
Equity
€447,087
2024 · €429,096+€17,991
Cash
€40,011
2024 · €15,664+€24,348
Balance sheet total
€1.2m
2024 · €1.3m-€69,109

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€98,796

    down €98,796 (-10.7%), from €922,468 to €823,672

    of which Trade receivables: -€205,700

  • Deferred charges and accrued income +€42,733

    up €42,733 (+31.9%), from €133,990 to €176,722

  • Stocks and contracts -€37,393

    down €37,393 (-20.4%), from €183,511 to €146,118

  • Cash +€24,348

    up €24,348 (+155.4%), from €15,664 to €40,011

    mainly Receivables within one year (+€98,796) and Stocks and contracts (+€37,393)

Equity and liabilities
  • Trade debts -€65,748

    down €65,748 (-8.7%), from €755,744 to €689,997

  • Other debts -€31,606

    down €31,606 (-52.5%), from €60,207 to €28,601

  • Profit (loss) carried forward +€17,991

    up €17,991 (+14.0%), from -€128,912 to -€110,921

Income statement
  • Gross operating margin -€44,422

    down €44,422 (-51.5%), from €86,272 to €41,850

  • Financial charges -€6,304

    down €6,304 (-64.3%), from €9,806 to €3,503

  • Staff costs +€3,300

    up €3,300 (+6.0%), from €54,697 to €57,997

  • Financial income +€1,221

    up €1,221 (+3.0%), from €41,023 to €42,244

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €60,443
Gross operating margin -€44,422
Staff costs -€3,300
Other operating charges -€31
Other operating items -€2,224
Financial income +€1,221
Financial charges +€6,304
Result 2025 €17,991

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€24,348
Investment €0
Financing €0
Cash 2024 €15,664
Net result for the year +€17,991
Stocks and contracts +€37,393
Receivables within one year +€98,796
Deferred charges and accrued income -€42,733
Trade debts -€65,748
Tax, wage and social debts +€8,551
Other debts -€31,606
Accrued charges and deferred income +€1,703
Cash 2025 €40,011
Every line side by side 39 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,259,533 €1,190,424 -€69,109 -5.5%
Fixed assets 21/28 €3,901 €3,901 = 0.0%
Financial fixed assets 28 €3,901 €3,901 = 0.0%
Current assets 29/58 €1,255,632 €1,186,524 -€69,109 -5.5%
Stocks and contracts in progress 3 €183,511 €146,118 -€37,393 -20.4%
Stocks 30/36 €183,511 €146,118 -€37,393 -20.4%
Amounts receivable within one year 40/41 €922,468 €823,672 -€98,796 -10.7%
Trade receivables 40 €379,983 €174,283 -€205,700 -54.1%
Other amounts receivable 41 €542,485 €649,390 +€106,904 +19.7%
Cash at bank and in hand 54/58 €15,664 €40,011 +€24,348 +155.4%
Deferred charges and accrued income 490/1 €133,990 €176,722 +€42,733 +31.9%
Total equity and liabilities 10/49 €1,259,533 €1,190,424 -€69,109 -5.5%
Equity 10/15 €429,096 €447,087 +€17,991 +4.2%
Contributions 10/11 €558,008 €558,008 = 0.0%
Capital 10 €558,008 €558,008 = 0.0%
Issued capital 100 €558,008 €558,008 = 0.0%
Profit (loss) carried forward 14 -€128,912 -€110,921 +€17,991 +14.0%
Amounts payable 17/49 €830,437 €743,337 -€87,099 -10.5%
Amounts payable within one year 42/48 €822,665 €733,862 -€88,803 -10.8%
Trade debts 44 €755,744 €689,997 -€65,748 -8.7%
Suppliers 440/4 €755,744 €689,997 -€65,748 -8.7%
Taxes, remuneration and social security 45 €6,714 €15,265 +€8,551 +127.4%
Taxes 450/3 €0 €9,035 +€9,035 +90348600.0%
Remuneration and social security 454/9 €6,714 €6,230 -€484 -7.2%
Other amounts payable 47/48 €60,207 €28,601 -€31,606 -52.5%
Accrued charges and deferred income 492/3 €7,772 €9,475 +€1,703 +21.9%
Non-recurring operating income 76A €393 €5,897 +€5,504 +1401.8%
Remuneration, social security and pensions 62 €54,697 €57,997 +€3,300 +6.0%
Other operating charges 640/8 €1,218 €1,248 +€31 +2.5%
Non-recurring operating charges 66A €1,132 €3,356 +€2,224 +196.4%
Gross operating margin 9900 €86,272 €41,850 -€44,422 -51.5%
Operating profit (loss) 9901 €29,226 -€20,751 -€49,976
Financial income 75/76B €41,023 €42,244 +€1,221 +3.0%
Recurring financial income 75 €41,023 €42,244 +€1,221 +3.0%
Financial charges 65/66B €9,806 €3,503 -€6,304 -64.3%
Recurring financial charges 65 €9,806 €3,503 -€6,304 -64.3%
Profit (loss) for the period before taxes 9903 €60,443 €17,991 -€42,452 -70.2%
Profit (loss) for the period 9904 €60,443 €17,991 -€42,452 -70.2%
Profit (loss) for the period to be appropriated 9905 €60,443 €17,991 -€42,452 -70.2%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.